VTGN — Vistagen Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Vistagen Therapeutics, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	68.1	16.6	119	80.5	45.4
Net Total Receivables	0.338	0.275	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71	17.5	121	82.1	46.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.08	2.77	2.25	1.81	1.23
Other Long Term Assets
Total Assets	74.6	21.1	124	84.3	48.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.77	4.57	5.12	12.6	12.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.93	9.01	9.37	14	13
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	64.7	12.1	114	70.4	35.5
Total Liabilities & Shareholders' Equity	74.6	21.1	124	84.3	48.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding